TrialTrials2013

A phase II, sham-controlled, double-blinded study testing the safety and efficacy of the coronary sinus reducer in patients with refractory angina: study protocol for a randomized controlled trial.

E Marc Jolicœur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.